1. Home
  2. ADUS vs ALMR Comparison

ADUS vs ALMR Comparison

Compare ADUS & ALMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Addus HomeCare Corporation

ADUS

Addus HomeCare Corporation

HOLD

Current Price

$111.96

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Logo Alamar Biosciences Inc. Common Stock

ALMR

Alamar Biosciences Inc. Common Stock

N/A

Current Price

$25.88

Market Cap

1.5B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
ADUS
ALMR
Founded
1979
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
2009
2026

Fundamental Metrics

Financial Performance
Metric
ADUS
ALMR
Price
$111.96
$25.88
Analyst Decision
Buy
Analyst Count
9
0
Target Price
$133.78
N/A
AVG Volume (30 Days)
250.6K
339.1K
Earning Date
05-04-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
23.40
N/A
EPS
1.36
N/A
Revenue
N/A
N/A
Revenue This Year
$9.17
N/A
Revenue Next Year
$4.70
N/A
P/E Ratio
$82.29
N/A
Revenue Growth
N/A
N/A
52 Week Low
$87.95
$21.58
52 Week High
$124.44
$29.43

Technical Indicators

Market Signals
Indicator
ADUS
ALMR
Relative Strength Index (RSI) N/A 53.27
Support Level N/A $23.88
Resistance Level N/A $29.06
Average True Range (ATR) 0.00 1.83
MACD 0.00 -0.29
Stochastic Oscillator 0.00 25.30

Price Performance

Historical Comparison
ADUS
ALMR

About ADUS Addus HomeCare Corporation

Addus HomeCare Corp is engaged in the provision of in-home care services. The Company has three reportable segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, mainly to the elderly, chronically ill, and disabled individuals. The Hospice segment provides physical, emotional, and spiritual care for terminally ill patients and their families. The Home Health segment provides medical services to individuals requiring care during illness or recovery. It generates the majority of its revenue from the Personal Care segment.

About ALMR Alamar Biosciences Inc. Common Stock

Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.

Share on Social Networks: